This inventor holds 19 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Gene Regulation. Top assignees: Intrexon Corporation, Rohm and Haas Company, Monsanto Company. Active years: 1977-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
10 out of 121 
7 out of 3,448 
1 out of 3,289 Years Active: 1977-2016
Areas of Expertise:
Title: Glenn Richard Carlson: Innovator in Gene Expression Technologies
Introduction
Glenn Richard Carlson, based in North Wales, PA, has made a significant impact in the field of biotechnology through his innovative work, holding a total of 19 patents. His contributions particularly focus on the modulation of gene expression, a vital area in genetic research and therapeutic development.
Latest Patents
Among his latest innovations is a patent for "Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex." This invention addresses non-steroidal ligands designed for use in a nuclear receptor-based inducible gene expression system. The methodology outlined in this patent involves an ecdysone receptor complex that comprises several critical components: a DNA binding domain, a ligand binding domain, a transactivation domain, and a ligand. When this complex interacts with a DNA construct containing an exogenous gene and a specific response element, it enables the activation or suppression of that gene, depending on the presence of the ligand.
Career Highlights
Glenn has worked with notable companies in the biotechnology sector, including Intrexon Corporation and Rohm and Haas Company. His tenure at these organizations has allowed him to refine his expertise and create impactful solutions that advance gene regulation technologies.
Collaborations
Throughout his career, Glenn has collaborated with other talented professionals, including Robert Eugene Hormann and David W. Potter. These partnerships have undoubtedly enriched his research and have facilitated the development of groundbreaking innovations in the field of genetics.
Conclusion
Glenn Richard Carlson continues to pave the way for advancements in gene expression technologies through his patents and collaborations. With his commitment to innovation, he plays a crucial role in shaping the landscape of biotechnology, proving that the potential for groundbreaking discoveries in genetic science is boundless.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile